Clinical Trials
2 trialsNCT07537257 2026-04-17
VEN+IDAC vs IDAC in AML
Guangdong Second Provincial General Hospital
Phase 2/3 Enrolling by invitation
NCT07264010 2025-12-04
Sorafenib Combined With Venetoclax as Pre-emptive Therapy Strategy for MRD+ AML: a Prospective, Single-arm, Multicenter Clinical Study
Nanfang Hospital, Southern Medical University
Phase 2/3 Not yet recruiting